Reagan’s Impact On User Fee Dates
This article was originally published in The Pink Sheet Daily
Executive Summary
CBER is treating June 11 as a holiday and will not extend any user fee dates. CDER is treating the office closure like any other (e.g. weather) and may extend user fee goals that fall near the date on a case-by-case basis.
You may also be interested in...
FDA Should Consider CFC Albuterol Phase-Out Date Beyond 2005 – Cmte.
Committee expresses concern about availability of albuterol HFA supply on chlorofluorocarbon phase-out date. Schering-Plough and GSK tell FDA it will take up to 18 months to expand annual production capacity to 30 mil. doses each.
FDA Cancels Meetings On Day Of Mourning For Reagan
Part 11 meeting on June 11 is cancelled and will not be rescheduled. The Anthrax Targeted Therapy Development workshop is rescheduled to begin and conclude on June 10 instead of running for two days.
Cardiome Oxyprim, Chronic Gout Drug Trials May Use Surrogate Endpoints For Approval, Cmte. Says
Surrogate endpoint should seek a reduction in serum uric acid to a level of 6 mg/dL. Clinical outcome trials to confirm benefits of chronic gout products through reduction in gouty attacks should be carried out post-approval.